Skip to content

Continuous Comprehensive Nursing for Post-CABG Recovery

Evaluating the Efficacy of a Continuous Comprehensive Nursing System on Postoperative Hemoglobin Levels and Quality of Life in Patients Undergoing Coronary Artery Bypass Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07062432
Enrollment
120
Registered
2025-07-14
Start date
2020-02-01
Completion date
2022-06-30
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease (CHD)

Keywords

Continuous comprehensive nursing system, Coronary artery bypass surgery, Hemoglobin levels, Quality of life, Nursing Efficacy

Brief summary

This study evaluates the effectiveness of a continuous comprehensive nursing (CCN) system compared to routine care for patients after coronary artery bypass graft (CABG) surgery. The primary goal is to determine if the CCN system improves postoperative hemoglobin levels. The study also investigates the effects on quality of life, mental health (anxiety and depression), red blood cell indices, immune markers, and patient satisfaction.

Detailed description

Coronary artery bypass surgery (CABG) is a major procedure, and the postoperative recovery process is complex, often impacting patients' hemoglobin levels and quality of life. Standard nursing care is often limited to the inpatient period. A continuous comprehensive nursing (CCN) system is a holistic, patient-centered model that extends care beyond hospital discharge. This model includes preoperative education, continuous monitoring, personalized care plans, psychological support, rehabilitation guidance, and structured follow-up. While the benefits of comprehensive nursing are recognized, its specific impact on hemoglobin recovery and quality of life after CABG has not been extensively studied. This randomized controlled trial was designed to compare the outcomes of patients receiving a CCN plan with those receiving routine postoperative care to provide evidence for optimizing post-CABG nursing strategies.

Interventions

BEHAVIORALContinuous Comprehensive Nursing System

A multi-faceted nursing plan delivered by trained cardiac nurses, extending from the preoperative phase to 3 months post-discharge. In addition to routine inpatient care, the intervention included: preoperative education and psychological support; postoperative individualized rehabilitation guidance; and a continuous post-discharge program. The post-discharge phase involved structured follow-up (monthly phone calls, one 6-week outpatient visit), ongoing psychological support, reinforcement of education on medication adherence, diet, and activity progression, and guidance on a structured home-based exercise program.

Standard institutional postoperative care for patients after Coronary Artery Bypass Graft (CABG) surgery. This care was primarily focused on the inpatient period and included monitoring of vital signs, wound and drainage tube management, respiratory and circulatory support, and progressive diet guidance. The care concluded with standard discharge instructions and did not include the structured, continuous, or extended follow-up provided to the intervention group.

Sponsors

The First Hospital of Hebei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 70 years. * Confirmed diagnosis of coronary heart disease and evidence of coronary artery illness requiring CABG. * Ability to understand the purpose and procedures of the study. * Willingness to sign the informed consent form.

Exclusion criteria

* Presence of serious complications such as unstable myocardial ischemia or significant arrhythmia. * Severe lung diseases (e.g., chronic obstructive pulmonary disease GOLD stage III/IV). * Severe kidney diseases (e.g., chronic kidney disease Stage 4/5). * Significantly impaired left ventricular ejection fraction (EF \< 30%). * Concurrent participation in other clinical trials or receiving other interventions. * Presence of severe mental illnesses or cognitive impairments.

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemoglobin (Hb) Levels from Baseline to Day 7 Post-SurgeryBaseline (preoperatively) and Day 7 post-surgery.The change in hemoglobin concentration (g/L) was measured from the preoperative baseline value to the value at 7 days after the surgery. Venous blood samples were analyzed using an automatic biochemical analyzer.

Secondary

MeasureTime frameDescription
Red Blood Cell IndicesDay 7 post-surgery.Measurement of Mean Corpuscular Volume (MCV, in fL), Red Blood Cell Distribution Width (RDW, in %), and Hematocrit (HCT, in %).
Levels of Immune-Related Inflammatory MarkersDay 7 post-surgery.Levels of Interleukin-2 (IL-2, in pg/mL) and Interleukin-6 (IL-6, in pg/mL) in peripheral blood, quantified using an ELISA kit.
Quality of Life (QoL)Day 14 post-surgery.Assessed using the World Health Organization Quality of Life BREF (WHOQOL-BREF) scale. This scale evaluates four domains: physical health, psychological health, social relationships, and environment. Higher scores indicate better quality of life.
Change in Hemoglobin (Hb) Levels at Other Time PointsBaseline, 12 hours, 72 hours, and 14 days post-surgery.Hemoglobin concentration (g/L) measured at multiple time points to assess the recovery trajectory.
Anxiety SymptomsDay 14 post-surgery.Assessed using the Self-Rating Anxiety Scale (SAS). The scale ranges from 20 to 80, with higher scores reflecting more severe anxiety symptoms.
Patient SatisfactionUp to 14 days post-surgery (at time of hospital discharge).Assessed using a study-specific satisfaction questionnaire. Responses were categorized as very satisfied, satisfied, average, or dissatisfied based on a scoring system from 1-100.
Depressive SymptomsDay 14 post-surgery.Assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The scale ranges from 0 to 60, with higher scores indicating more severe depressive symptoms.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026